Clinical trial

Bevacizumab and Endothelium Dependent Vasodilation

NCT01125943

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2010-06-01

PhaseNA

Study timeline

Study start (unknown)2010-06-01Date precision: month

Registry last updated2013-01-10

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Hypertensionunresolved

Cancerverified · MONDO: cancer

Endothelial Dysfunctionunresolved

Interventions

AcetylcholineDRUG · verified · RxNorm: acetylcholine

NitroprussideDRUG · verified · RxNorm: nitroprusside

BevacizumabDRUG · verified · RxNorm: bevacizumab

Sponsors & collaborators

Radboud University Medical Centerlead sponsor

Dutch Cancer Societycollaborator

Mapped research locations

NijmegenNetherlands1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01125943 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.